Identifying these vulnerable adolescents, including through genetic or psychological screening, may be crucial for prevention and early intervention of addiction and psychiatric disorders linked to cannabis use. The objective is not to fuel the debate about whether cannabis is bad or good, but instead to identify those people who might most have problems with its deleterious effects and provide adequate measures to avoid this risk’ Jutras-Aswad said. ‘Continuing research should be performed to inform public policy in this region. Without such systematic, evidenced-based research to comprehend the long-term ramifications of cannabis on the developing mind, not merely the legal status of cannabis shall be determined on uncertain surface, but we will not be in a position to innovate effective treatments like the medicinal use of cannabis plant components that might be good for treating specific disorders,’ Dr Hurd said.Peter Davies, M.D., Ph.D., provost and executive vice president for study at The University of Texas Wellness Science Center at Houston , may be the principal investigator and can also serve simply because the program’s co-director with Michael Mancini, Ph.D., associate professor and director of the Integrated Microscopy Primary at Baylor College of Medicine. The primary goal of the program will be to accelerate the movement of simple discoveries in cancer analysis into clinical application through provision of important resources to support drug discovery research and therapeutics advancement in Texas, Davies stated. By combining state-of-the-art laboratory technology with a sophisticated plan of informatics for data mining and data posting, the scheduled program allows cancer researchers to choose the most promising network marketing leads, new molecules or drugs which have the highest probability of success in their way to development of fresh cancer tumor therapies.